glp-1 ibd GLPs as novel therapeutic options in IBD-potential mechanisms of action OBESITY AND IBD by @EdwardLoftus2

Role of glucagon-like peptide-1 receptor agonists in the management of non-alcoholic steatohepatitis: A clinical review article

Here's 10$ off from your friend Discount code copied

These findings emphasize that targeted antagonism of NMDA receptor signalling lowers body weight independently of MC4R, indicating that this preclinical drug candidate might not only be effective in treating polygenic obesity but also holds potential as an effective weight loss strategy for patients with loss-of-function mutations in MC4R , the most common form of monogenic obesity 32

Myth: Weight Loss Achieved with GLP-1 Injections Is Permanent Fact: While GLP-1 receptor agonists can lead to significant weight loss, maintaining this loss requires ongoing lifestyle changes